SCHEMBL31358973

SCHEMBL31358973

Cc1nccc2[nH]c(=O)n(CC(=O)N[C@H](C)c3ncc(C#N)cc3F)c(=O)c12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ITGB1 P05556 1/20 0.36
▸ ITGAV P06756 1/20 0.36
▸ ITGA5 P08648 1/20 0.36
▸ ITGA4 P13612 1/20 0.36
▸ GPR139 Q6DWJ6 7/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ TSHR P16473 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ S1PR3 Q99500 1/20 0.33
▸ APLNR P35414 1/20 0.32
▸ PDPK1 O15530 1/20 0.32
▸ GRIN1 Q05586 2/20 0.32
▸ GRIN2B Q13224 2/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ CNR2 P34972 1/20 0.32
▸ POLB P06746 2/20 0.32
▸ JAK2 O60674 1/20 0.32
▸ JAK3 P52333 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31160937 1.00 ITGB1 (0.36) ITGB1ITGAVITGA5ITGA4GPR139
SCHEMBL31358984 0.89 GPR139 (0.35) ITGB1ITGAVITGA5ITGA4GPR139
SCHEMBL31359011 0.89 GPR139 (0.35) ITGB1ITGAVITGA5ITGA4GPR139
SCHEMBL31359074 0.89 GPR139 (0.39) ITGB1ITGAVITGA5ITGA4GPR139
SCHEMBL31359020 0.89 GPR139 (0.39) ITGB1ITGAVITGA5ITGA4GPR139
SCHEMBL31359030 0.89 ITGB1 (0.36) ITGB1ITGAVITGA5ITGA4GPR139
SCHEMBL31359019 0.88 PDPK1 (0.36) ITGB1ITGAVITGA5ITGA4GPR139
SCHEMBL31359142 0.88 KDM4E (0.37) ITGB1ITGAVITGA5ITGA4GPR139
SCHEMBL31161003 0.88 PDPK1 (0.36) ITGB1ITGAVITGA5ITGA4GPR139
SCHEMBL31359025 0.88 KDM4E (0.37) ITGB1ITGAVITGA5ITGA4GPR139

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12559464-B2 Quinazolinone dione compounds and uses thereof EDGEWISE THERAPEUTICS, INC. (US) 2026-02-24 — — US disclosed
US-20250026726-A1 QUINAZOLINONE DIONE COMPOUNDS AND USES THEREOF EDGEWISE THERAPEUTICS, INC. 2025-01-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250026726-A1 QUINAZOLINONE DIONE COMPOUNDS AND USES THEREOF TNNI3, TNNT2, MYLK2 ITGB1 4506/4885ITGAV 4631/4885ITGA5 4414/4885
US-12559464-B2 Quinazolinone dione compounds and uses thereof TNNI3, TNNT2, TNNC1 ITGB1 1810/4885ITGAV 4526/4885ITGA5 3185/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback